1. Agarwal, R., Gort, M.: First-mover advantage and the speed of competitive entry 1887–1986. J. Law Econ. 44, 161–177 (2001)
2. Angell, M.: The truth about the drug companies. In: Chadha, A., Blomqvist, A. (eds.) Patent races, “me-too” drugs, and generics: a developing world perspective. Random House, New York. National University of Singapore. Department of Economics, Working Paper No. 0513 (2004)
3. Banbury, C.M., Mitchell, W.: The effect of introducing important incremental innovations on market share and business survival. Strateg. Manag. J. 16, 161–182 (1995)
4. Cavalla, D.: Therapeutic switching: a new strategic approach to enhance R&D productivity. IDrugs 8(11), 914–918 (2005)
5. Chadha, A., Blomqvist, A.: Patent races, “me-too” drugs, and generics: a developing world perspective. National University of Singapore. Department of Economics, Working Paper No. 0513 (2005)